Eton Pharmaceuticals Inc. (ETON) Tops Q4 EPS by 5c
Tweet
Share
E-mailGet Alerts ETON Hot Sheet
Join SI Premium – FREE
Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q4 EPS of $0.04, $0.05 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $8.98 million.
For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
- zSpace, Inc. (ZSPC) Reports Q2 results
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
